Medical Supplies and Services News

イスタンブール発 , June 20, 2026 (GLOBE NEWSWIRE) -- 欧州アレルギー・臨床免疫学会 (European Academy of Allergy and Clinical Immunology、EAACI) は、イスタンブールで開催された2026年年次総会を成功裏に閉幕した。同総会には、「ビジョン・ゼロ：アレルギーと喘息の負担から解放される未来 (Vision...

이스탄불, June 20, 2026 (GLOBE NEWSWIRE) -- 유럽알레르기임상면역학회(European Academy of Allergy and Clinical Immunology·EAACI)는 “비전 제로: 알레르기와 천식 부담이 없는 미래(Vision Zero: A Future Free from Allergy and Asthma...

ISTANBUL, June 20, 2026 (GLOBE NEWSWIRE) -- European Academy of Allergy and Clinical Immunology (EAACI) telah berjaya menganjur dan menamatkan Kongres Tahunan 2026 di Istanbul dengan kejayaan...

ISTAMBUL, June 19, 2026 (GLOBE NEWSWIRE) -- A European Academy of Allergy and Clinical Immunology (EAACI) concluiu com sucesso seu Congresso Anual de 2026 em Istambul, reunindo 7.429 delegados de...

ESTAMBUL, June 19, 2026 (GLOBE NEWSWIRE) -- La Academia Europea de Alergia e Inmunología Clínica (EAACI) concluyó con éxito su Congreso Anual 2026 en Estambul, reuniendo a 7.429 delegados de 110...

อิสตันบูล, June 20, 2026 (GLOBE NEWSWIRE) -- สมาคม European Academy of Allergy and Clinical Immunology (EAACI) ได้ปิดฉากการประชุมประจำปี Congress 2026 อย่างประสบความสำเร็จ ณ นครอิสตันบูล...

EAACI Congress 2026 concluded in Istanbul, welcoming 7,429 delegates from 110 countries and marking the start of Mohamed Shamji's Presidency.

Diazyme receives FDA 510(k) clearance for its isoform‑independent Lipoprotein(a) Molarity Assay, improving standardized cardiovascular risk assessment.

NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a company that develops and acquires technologies for defense, security, and first-response markets, today...

EssilorLuxottica and Applied Materials Join Forces to Advance Augmented Reality Optics Platforms for Next-Generation Smart Glasses Joint development agreement aims to accelerate commercialization of...